Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors

Clinical trial NCT01151670 · COMPLETED

Trial details

NCT number: NCT01151670
Sponsor: Wake Forest University Health Sciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain Neoplasms, Malignant Brain Neoplasms, Benign Malignant Meningioma Glioblastoma Multiforme Anaplastic Astrocytoma

Start date: 2010-08-01
Primary completion: 2014-08-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.